SCHEMBL24601458

SCHEMBL24601458

CC(C)(O)O[C@@H]1C[C@@H](C(=O)O)O[C@H]1n1cnc2c(N)nc(Cl)nc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.50
NT5E P21589 10/20 0.48
DNMT1 P26358 1/20 0.47
DNMT3B Q9UBC3 1/20 0.47
CD99 P14209 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA9 Q16790 1/20 0.46
PDE4D Q08499 2/20 0.45
PDE3A Q14432 2/20 0.45
PNP P00491 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
ADORA2A P29274 2/20 0.44
ADORA1 P30542 2/20 0.44
ADORA2B P29275 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601222 0.84 PDE4D (0.52) ADORA3NT5ECA1CA2CA4
SCHEMBL20333764 0.84 PDE4D (0.52) ADORA3NT5ECA1CA2CA4
SCHEMBL12826793 0.73 PDE4D (0.55) ADORA3NT5EDNMT1DNMT3BCD99
SCHEMBL23586006 0.73 PDE4D (0.55) ADORA3NT5ECD99CA1CA2
SCHEMBL20333318 0.72 PDE4D (0.52) ADORA3NT5ECD99CA1CA2
SCHEMBL24600770 0.71 ADORA3 (0.51) ADORA3NT5EADORA2AADORA1
SCHEMBL20334131 0.70 NT5E (0.53) ADORA3NT5ECD99CA1CA2
SCHEMBL19157474 0.70 ADORA3 (0.67) ADORA3NT5EDNMT1CA1CA2
SCHEMBL22757359 0.70 ADORA3 (0.52) ADORA3ADORA2AADORA1ADORA2B
SCHEMBL12746571 0.70 PDE4D (0.68) ADORA3NT5EDNMT1DNMT3BCD99

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022143740-A1 ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF 浙江春禾医药科技有限公司 2022-07-07 WO disclosed